NOVOHALE THERAPEUTICS
Live / Allowed — Second extension granted (statement of use) (as of 19 May 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 25 Jul 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98666258
- Mark type
- Word mark
- Filed
- 25 Jul 2024
- Published for opposition
- 25 Mar 2025
- Attorney of record
- Ryan A. Murr
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of psychiatric disorders; Prescription medicines for the treatment of psychiatric disorders; Medical preparations for the treatment of psychiatric disorders
- Class 042 — Scientific and technological services: Pharmaceutical research and development in the field of psychiatric disorders; Medical research and development in the field of psychiatric disorders
Owner
- Novohale Therapeutics, LLC, San Diego, CA, US
- Novohale Therapeutics, LLC, San Diego, CA, US
Prosecution history
- 20 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 May 2026 — SOU EXTENSION 2 GRANTED
- 19 May 2026 — SOU EXTENSION 2 FILED
- 19 May 2026 — SOU TEAS EXTENSION RECEIVED
- 19 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Nov 2025 — SOU EXTENSION 1 GRANTED
- 18 Nov 2025 — SOU EXTENSION 1 FILED
- 18 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 20 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Mar 2025 — PUBLISHED FOR OPPOSITION
- 19 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Feb 2025 — EXAMINER'S AMENDMENT ENTERED
- 06 Feb 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED